•
Jun 30, 2024

PTC Therapeutics Q3 2024 Earnings Report

Total Revenue
$187M
Previous year: $197M
-5.0%
EPS
-$1.39
Previous year: -$1.76
-21.0%
Gross Profit
$183M
Previous year: $187M
-2.2%
Cash and Equivalents
$1.01B
Previous year: $295M
+243.7%
Free Cash Flow
-$77.5M
Previous year: -$20.9M
+271.3%
Total Assets
$1.84B
Previous year: $1.26B
+46.2%

PTC Therapeutics

PTC Therapeutics